Click on the links below to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.
A small proportion of Ontario doctors who treat people battling opioid addictions prescribe the majority of the medications used to treat the disorder, a study has found, raising concerns about the quality of patient care and access to therapy.
Ontario has seen an almost fourfold jump in the rate of opioid-related deaths over the past 25 years, according to a report published Thursday.
Medically sanctioned opioid use has dropped by almost 14 per cent since national guidelines for prescribing the drugs were introduced in 2010, yet the rate of overdose-related hospital visits continued to rise, an Ontario study has found.
Canadian doctors are increasingly medicating children with antidepressants and antipsychotics, suggests a new study experts worry is the latest sign of using drugs to achieve “behavioural control.”
The introduction of reimbursement limits for blood glucose test strips had no impact on rates of emergency department (ED) visits for hypoglycemia or hyperglycemia, or on mean hemoglobin A1c levels, according to a Canadian study.
New research reveals painkiller overdoses happening most often in northeastern part of province.
An average of two people die from opioid overdoses in Ontario each day, but unlike other other provinces across the country — there is no real time monitoring system in place to provide a comprehensive look at the issue.
September 23, 2016 | Global News | News Article
In the absence of national data on opioid prescribing and overdoses, we have no way to capture the problem or to identify policy solutions.
September 6, 2016 | Toronto Star | News Article
Adults with ADHD face numerous barriers in accessing a diagnosis and treatment – not the least of which is that the first-line treatment is not publicly available to adults in many provinces.
Only a small number of palliative-care patients in Ontario will be affected by the province’s plan to stop paying for high-dose opioid medications under its public drug programs, a new study shows.